1. Home
  2. BGH vs QSI Comparison

BGH vs QSI Comparison

Compare BGH & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGH
  • QSI
  • Stock Information
  • Founded
  • BGH 2012
  • QSI 2013
  • Country
  • BGH United States
  • QSI United States
  • Employees
  • BGH N/A
  • QSI N/A
  • Industry
  • BGH Investment Managers
  • QSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGH Finance
  • QSI Health Care
  • Exchange
  • BGH Nasdaq
  • QSI Nasdaq
  • Market Cap
  • BGH 318.2M
  • QSI 284.0M
  • IPO Year
  • BGH N/A
  • QSI N/A
  • Fundamental
  • Price
  • BGH $15.29
  • QSI $1.28
  • Analyst Decision
  • BGH
  • QSI Buy
  • Analyst Count
  • BGH 0
  • QSI 2
  • Target Price
  • BGH N/A
  • QSI $3.25
  • AVG Volume (30 Days)
  • BGH 61.5K
  • QSI 18.3M
  • Earning Date
  • BGH 01-01-0001
  • QSI 11-12-2024
  • Dividend Yield
  • BGH 10.06%
  • QSI N/A
  • EPS Growth
  • BGH N/A
  • QSI N/A
  • EPS
  • BGH N/A
  • QSI N/A
  • Revenue
  • BGH N/A
  • QSI $2,266,000.00
  • Revenue This Year
  • BGH N/A
  • QSI $193.90
  • Revenue Next Year
  • BGH N/A
  • QSI $173.18
  • P/E Ratio
  • BGH N/A
  • QSI N/A
  • Revenue Growth
  • BGH N/A
  • QSI 232.26
  • 52 Week Low
  • BGH $11.92
  • QSI $0.61
  • 52 Week High
  • BGH $14.50
  • QSI $2.58
  • Technical
  • Relative Strength Index (RSI)
  • BGH 36.06
  • QSI 47.96
  • Support Level
  • BGH $15.73
  • QSI $1.17
  • Resistance Level
  • BGH $16.34
  • QSI $2.58
  • Average True Range (ATR)
  • BGH 0.21
  • QSI 0.33
  • MACD
  • BGH -0.10
  • QSI -0.06
  • Stochastic Oscillator
  • BGH 19.38
  • QSI 11.90

About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests

Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.

Share on Social Networks: